PATENT CLAIM ANALYSIS

Application Number: 15927948
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "210200"]

Abstract:
The present invention relates to compounds of Formula (I): Wherein variables are as defined above. The compounds have apoptosis signal-regulating kinase (“ASK”) inhibitory activity, and are thus useful in the treatment of ASK1-mediated conditions, including autoimmune disorders, inflammatory diseases, cardiovascular diseases, diabetes, diabetic nephropathy, cardio-renal diseases, including kidney disease, fibrotic diseases, respiratory diseases, COPD, idiopathic pulmonary fibrosis, acute lung injury, acute and chronic liver diseases, and neurodegenerative diseases.

Claim (Index 16):
The compound of  claim 15 , having the structure:

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.5082
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14135812', '15357878', '14570655', '15105372', '13174459']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8293422766813636
- 35 USC 102 Novelty (BERT): 0.5354681748890157
- Combined Prediction Score: 0.7999548665021289
- Mean Citation Score: 393.702882
- Max Citation Score: 417.28247000000016
- Similarity Product: 151.44479933296327

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test